PDXK ‐Related Neuropathy: A Case With a Novel Splice‐Altering Missense Variant and Literature Review
Open Access
- 26 March 2026
- journal article
- case report
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (4) , e70210
Abstract
Background: PDXK ‐related neuropathy is a rare form of hereditary motor and sensory neuropathy with optic atrophy, caused by biallelic variants in the PDXK gene. To date, only four missense variants have been reported in 13 patients from six families. Unlike most inherited neuropathies, which currently have only symptomatic treatments, this type of neuropathy can be managed with pyridoxal 5′‐phosphate supplementation. Methods: The clinical presentation of the patient was evaluated twice, at ages 14 and 15 years. The whole‐exome sequencing was performed for the proband followed by functional studies using RNA extracted from the proband's and proband's mother's peripheral blood mononuclear cells. Results: In this study, we provided a brief literature review on PDXK ‐related neuropathy and reported a female patient with a novel missense variant (c.826G>C, p.(Ala276Pro)) found in compound heterozygous state with a previously reported variant (c.659G>A, p.[Arg220Gln]) in the PDXK gene. Additionally, she carried a novel likely pathogenic missense variant (c.1180C>T, p.[Arg394Cys]) in the GCK gene, associated with MODY2, which was segregated with hyperglycemia in her family. The novel variant c.826G>C in the PDXK gene was predicted to disrupt splicing that was confirmed by our functional studies. The patient exhibited typical peripheral neuropathy but no optic atrophy, likely due to her young age. Conclusions: Here we report a novel splice‐altering missense variant in PDXK that induces aberrant transcript degradation, revealing a new disease mechanism for PDXK ‐related neuropathy.Keywords
Funding Information
- Russian Science Foundation (№ 25‐65‐00031)
This publication has 15 references indexed in Scilit:
- Clinical Characteristics of Gait Disturbance in Charcot-Marie-Tooth Disease and Future Directions in Physical TherapyCureus, 2025
- Developing a gene therapy for Charcot-Marie-Tooth disease: progress and challengesRegenerative Medicine, 2025
- Hereditary polyneuropathy with optic atrophy due to PDXK variant leading to impaired Vitamin B6 metabolismNeuromuscular Disorders, 2020
- PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementationAnnals of Neurology, 2019
- GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variantsDiabetes Research and Clinical Practice, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic ReviewNeuroepidemiology, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding – explains hyperglycemia in type 2 diabetic patientsJournal of Biomolecular Structure and Dynamics, 2014
- Novel glucokinase mutations in patients with monogenic diabetes – clinical outline of GCK‐MD and potential for founder effect in Slavic populationClinical Genetics, 2011